Skip to main content
. 2020 Jul 14;8:454. doi: 10.3389/fcell.2020.00454

FIGURE 1.

FIGURE 1

Compound design strategy by introducing various biologically active fragments to the terminal cap of vorinostat. The three parts of the HDAC inhibitor pharmacophore are indicated in different colors.